Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia - Concepedia

Concepedia

Publication | Open Access

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

DOI Full Paper Access

65

Citations

12

References

2016

Year

Bo Cai, Mei Guo, Yao Wang, Jun J. Yang, Yelei Guo, Hanren Dai, Chang‐Lin Yu, Qi‐Yun Sun, Jian‐Hui Qiao, Kai‐Xun Hu,

Journal of Hematology & Oncology

Abstract

Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL. NCT02799550.

References

	Year	Citations
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, New England Journal of Medicine	2014	5.3K
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, The Lancet T CellsT-regulatory CellImmunologyHematologyAutoimmunity	2014	2.9K
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease Jennifer N. Brudno, Robert Somerville, Victoria Shi, Journal of Clinical Oncology	2016	596
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells Saar Gill, Sarah K. Tasian, Marco Ruella, Blood	2014	481
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti, Blood	2000	240
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Donna Przepiorka, Nancy A. Kernan, Cindy Ippoliti, Blood	2000	238
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia Hanren Dai, Wenying Zhang, Xiaolei Li, OncoImmunology	2015	164
Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients Mei Guo, Kai‐Xun Hu, Chang‐Lin Yu, Blood	2010	109
HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up Mei Guo, Kai‐Xun Hu, Guangxian Liu, Journal of Clinical Oncology	2012	94
First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL Waseem Qasim, Persis Amrolia, Sujith Samarasinghe, Blood	2015	94

Page 1